FPH ASX Week ended 31 Jul 2026

Weekly Investor Report

Name: FPH weekly investor report
Creator: Sharemaestro
License: https://sharemaestro.com/data-license/

Fisher & Paykel Healthcare Corporation Limited · Healthcare · Medical Instruments & Supplies

Open interactive chart View report data

Latest close 34.02 AUD

4.1% latest week

Weekly setup

Mixed setup

The weekly trend is not active. Price is 7.8% above the Trend Line and sits at 87.4% of its 52-week range. The latest completed week returned 4.1%, after a 3.9% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is expensive relative to peers. The latest news-sentiment score is 54/100.

Setup score 52 out of 100

Latest Close 34.02 AUD 31 Jul 2026

1W Return 4.1% latest completed week

4W Return 3.9% short-term follow-through

12W Return 18.3% quarterly tape

Trend Breadth 17.3% 9 of 52 weeks active

Volume Ratio 1.1x vs 13-week average

What is working

Price is above the Trend Line, keeping the weekly tape constructive.
Price is above Fair Value, showing premium demand versus the model.
Activity pressure is positive on the latest completed week.

What could go wrong

The trend backdrop is inactive, so price action has not confirmed a constructive regime.
Activity pressure is weak, so confirmation is not yet broad enough.
9 reversal markers appear in the recent smart-money tape.

What to watch next

Price is close to its 52-week high; watch for continuation or exhaustion.
Trend Line remains the key weekly regime level.
Activity pressure is the gauge to monitor for confirmation or fade.
A volume ratio above 1.5x would show stronger participation in the next move.

Price follow-through 4.1% Latest completed week; four-week move 3.9%. Indicator stack 10/74 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 54/100 37 relevant articles in the latest sentiment read.

01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is 7.8% above the Trend Line and sits at 87.4% of its 52-week range. The latest completed week returned 4.1%, after a 3.9% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value

Price Trend Line Fair Value

Position in the 52-week range

Close Trend Fair

26.28 AUD 87.4% 35.13 AUD

Range location87.4%Shows where the latest close sits between the 52-week low and high.

Trend distance7.8%Price premium or discount versus the weekly Trend Line.

Fair-value gap16.9%Premium demand or model discount versus Sharemaestro Fair Value.

High-water gap-3.2%Distance from the latest 52-week high.

02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.1x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction

6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul

Up week Down week

Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.3212-week average 0.14

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.

Positive pressure6/12Weeks with constructive activity pressure in the latest 12-week window.

Positive leadership5/12Weeks with positive relative leadership in the latest 12-week window.

Activity pressure0.32Current proprietary activity-pressure read.

Buy signals0Accumulation signal count in the latest 12 weeks.

Reversal markers99 reversal markers

No recent accumulation markers. 9 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 3.9% over four weeks, 18.3% over 12 weeks, and 4.0% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W4.1%

4W3.9%

12W18.3%

26W1.1%

52W4.0%

Active trend streak0 weeks

Active weeks in one year9

Trend breadth17.3%

Activity pressure vs relative leadership

Activity pressureRelative leadership

Pressure0.91Latest activity-pressure read.

Pressure change94.7%Four-week change in activity pressure.

Leadership4.01Latest relative-leadership reading.

RS change161.5%Four-week change in relative leadership.

04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is expensive relative to peers.

Open full factor analysis

Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 85% Model confidence 81%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength22/100Blend of value, momentum, and quality. Underlying universe rank 79; rank 1 is best.

Value2/100Relative valuation strength. Underlying universe rank 99; rank 1 is best.

Quality98/100Profitability and accounting quality. Underlying universe rank 3; rank 1 is best.

Momentum18/100Medium-term price momentum. Underlying universe rank 83; rank 1 is best.

Growth98/100Revenue and earnings growth. Underlying universe rank 3; rank 1 is best.

How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework24/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E: 41.0x
Price / sales: 8.3x
EV / EBITDA: 23.6x
Free-cash-flow yield: 2.5%

Business quality

Margins and the return generated on invested capital.

Gross margin: 63.7%
Operating margin: 20.7%
Free-cash-flow margin: 20.3%
Return on invested capital: 19.9%

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth: 80.3%
EPS growth: 23.4%
Free-cash-flow growth: 5.0%
Piotroski F-score: 5/9

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield: 1.3%
Buyback yield: -0.0%
Shareholder yield: 1.3%
Net debt / EBITDA: -0.4x

05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment54/100

Weighted news tone is neutral across 37 relevant articles.

10 positive · 25 neutral · 2 negative

Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal

06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.

Options expected move-Nearest-chain priced movement where available.

52-week drawdown-3.2%Distance below the 52-week high.

13-week volatility4.6%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

6 Feb 6 Mar 3 Apr 1 May 29 May 26 Jun 31 Jul

Weeks higher13 of 2613 weeks finished lower.

Best week+12.7%Week of 29 May.

Worst week-6.9%Week of 15 May.

Latest week+4.1%Week of 31 Jul.

Shape of recent returns

Strong gains5

Modest gains8

Flat weeks0

Modest losses8

Sharp losses5

Recent vol4.6%13-week weekly-return volatility.

Base vol3.8%52-week weekly-return volatility.

Up/down split27/25Count of positive and negative weeks in the 52-week window.

Average skew3.0% / -2.9%Average positive week versus average negative week.

07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

SectorAU Healthcare

4-week rank23 / 100

Group average-5.0%

Trend breadth23.0%

Trend23.0%active weekly trend signals

MD60.0%positive activity pressure

RS24.0%positive relative leadership

Four-week leaders

RHT · ASX45.5%AFP · ASX36.2%TTX · ASX27.4%PTX · ASX25.0%EYE · ASX23.8%

IndustryAU Medical Instruments & Supplies

4-week rank2 / 8

Group average-3.1%

Trend breadth12.5%

Trend12.5%active weekly trend signals

MD62.5%positive activity pressure

RS37.5%positive relative leadership

Four-week leaders

OSX · ASX12.5%FPH · ASX3.9%SDI · ASX3.1%ANN · ASX1.0%RMD · ASX-2.3%

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape46/100

Trend, activity pressure, participation, and risk combine to a 46/100 tape read.

Indicator analysis24/100

Latest 12-week confirmation: trend 0/12, activity pressure 6/12, relative leadership 5/12.

Activity pressure 0.32; 9 reversal markers Factors35/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 65 SVQF24/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 200.5 of 262 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment54/100

Weighted news tone is neutral across 37 relevant articles.

GE HealthCare’s (NASDAQ:GEHC) Q2 CY2026: Beats On Revenue, Stock Soars Insiders50/100

No recent insider transaction evidence is stored.

Earnings50/100

No stored earnings event is currently attached to this ticker.

Week	Close	Return	Trend Line	Fair Value	Pressure	Leadership	Volume	Trend
31 Jul 2026	34.02 AUD	4.1%	31.56 AUD	29.11 AUD	0.91	4.01	1.6M	Off
24 Jul 2026	32.68 AUD	-1.9%	31.50 AUD	29.03 AUD	0.88	2.25	1.2M	Off
17 Jul 2026	33.31 AUD	1.2%	31.50 AUD	28.96 AUD	0.83	3.90	1.1M	Off
10 Jul 2026	32.93 AUD	0.6%	31.47 AUD	28.89 AUD	0.70	2.59	1.6M	Off
3 Jul 2026	32.74 AUD	3.7%	31.46 AUD	28.82 AUD	0.47	1.53	1.7M	Off
26 Jun 2026	31.57 AUD	1.0%	31.47 AUD	28.75 AUD	0.10	-1.31	349.0K	Off
19 Jun 2026	31.26 AUD	-2.2%	31.52 AUD	28.69 AUD	-0.17	-3.16	485.0K	Off
12 Jun 2026	31.95 AUD	5.1%	31.53 AUD	28.62 AUD	-0.52	-0.96	397.8K	Off
5 Jun 2026	30.42 AUD	-1.6%	31.55 AUD	28.55 AUD	-0.92	-3.92	2.1M	Off
29 May 2026	30.90 AUD	12.7%	31.64 AUD	28.49 AUD	-1.19	-3.79	542.0K	Off
22 May 2026	27.41 AUD	2.4%	31.68 AUD	28.43 AUD	-1.40	-14.12	3.2M	Off
15 May 2026	26.76 AUD	-6.9%	31.81 AUD	28.39 AUD	-1.48	-16.25	3.0M	Off
8 May 2026	28.75 AUD	-2.1%	31.96 AUD	28.38 AUD	-1.31	-11.62	1.8M	Off
1 May 2026	29.36 AUD	0.6%	32.05 AUD	28.35 AUD	-1.09	-9.94	1.6M	Off

How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.